Dr. Grothey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7945 Wolf River Blvd
Germantown, TN 38138Phone+1 901-683-0055
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2003 - 2005
- Ruhr - University Bochum Faculty of MedicineClass of 1987
Certifications & Licensure
- TN State Medical License 2019 - 2026
- AZ State Medical License 2018 - 2022
- MN State Medical License 2005 - 2019
Publications & Presentations
PubMed
- Phase I-II study of OBI-888, a humanized monoclonal IgG1 antibody against the tumor-associated carbohydrate antigen Globo H, in patients with advanced solid tumors.Apostolia Maria Tsimberidou, Axel Grothey, Darren Sigal, Heinz-Josef Lenz, Howard S Hochster
Cancer Chemotherapy and Pharmacology. 2024-12-01 - HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analys...Salvatore Siena, Kanwal Raghav, Toshiki Masuishi, Kensei Yamaguchi, Tomohiro Nishina
Nature Communications. 2024-11-25 - Prognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysis.Romain Cohen, Morteza Raeisi, Benoist Chibaudel, Qian Shi, Takayuki Yoshino
European Journal of Cancer. 2024-08-01
Press Mentions
- West Cancer Center & Research Institute Specialists Featured at Prestigious Oncology EventJune 13th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: